Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Intrinsic Value
Sunshine Guojian Pharmaceutical Shanghai Co Ltd is a China-based company mainly engaged in the research and development, industrialization and commercialization of antibody drugs. [ Read More ]
The intrinsic value of one Sunshine Guojian Pharmaceutical Shanghai Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 23.76 CNY, Sunshine Guojian Pharmaceutical Shanghai Co Ltd is hidden .
Valuation Backtest
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Run backtest to discover the historical profit from buying and selling Sunshine Guojian Pharmaceutical Shanghai Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
| Current Assets | 2.4B |
| Cash & Short-Term Investments | 1.8B |
| Receivables | 157.6m |
| Other Current Assets | 449.7m |
| Non-Current Assets | 2.6B |
| Long-Term Investments | 103.4m |
| PP&E | 1.5B |
| Intangibles | 338.1m |
| Other Non-Current Assets | 687.6m |
| Current Liabilities | 224.4m |
| Accounts Payable | 20.4m |
| Accrued Liabilities | 37m |
| Short-Term Debt | 50m |
| Other Current Liabilities | 116.9m |
| Non-Current Liabilities | 107.5m |
| Other Non-Current Liabilities | 107.5m |
Earnings Waterfall
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
|
Revenue
|
962.7m
CNY
|
|
Cost of Revenue
|
-240.8m
CNY
|
|
Gross Profit
|
721.9m
CNY
|
|
Operating Expenses
|
-597.1m
CNY
|
|
Operating Income
|
124.8m
CNY
|
|
Other Expenses
|
26.4m
CNY
|
|
Net Income
|
151.2m
CNY
|
Free Cash Flow Analysis
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Profitability Score
Profitability Due Diligence
Sunshine Guojian Pharmaceutical Shanghai Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Sunshine Guojian Pharmaceutical Shanghai Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Sunshine Guojian Pharmaceutical Shanghai Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Sunshine Guojian Pharmaceutical Shanghai Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
According to Wall Street analysts, the average 1-year price target for Sunshine Guojian Pharmaceutical Shanghai Co Ltd is 11.35 CNY with a low forecast of 11.24 CNY and a high forecast of 11.69 CNY.
Shareholder Return
Price
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
| Average Annual Return | -36.51% |
| Standard Deviation of Annual Returns | 15.99% |
| Max Drawdown | -77% |
| Market Capitalization | 14.7B CNY |
| Shares Outstanding | 616 786 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sunshine Guojian Pharmaceutical Shanghai Co Ltd is a China-based company mainly engaged in the research and development, industrialization and commercialization of antibody drugs. Its products are mainly used to treat major diseases such as autoimmune diseases and tumors. The Company’s product, recombinant human type II tumor necrosis factor receptor-antibody fusion protein (trade name: YISAIPU), is a fully human antibody drug used to treat rheumatoid arthritis, ankylosing spondylitis and psoriasis. The Company mainly conducts its businesses in Mainland China.
Contact
IPO
Employees
Officers
The intrinsic value of one Sunshine Guojian Pharmaceutical Shanghai Co Ltd stock under the Base Case scenario is hidden CNY.
Compared to the current market price of 23.76 CNY, Sunshine Guojian Pharmaceutical Shanghai Co Ltd is hidden .
You don't have any saved screeners yet
